GARP as a Therapeutic Target for the Modulation of Regulatory T Cells in Cancer and Autoimmunity.

Zimmer, Niklas; Trzeciak, Emily R; Graefen, Barbara; Satoh, Kazuki; Tuettenberg, Andrea

Zimmer, Niklas; Trzeciak, Emily R; Graefen, Barbara; Satoh, Kazuki; Tuettenberg, Andrea.

Afiliación

Zimmer N; Department of Dermatology, University Medical Center Mainz, Johannes Gutenberg University Mainz, Mainz, Germany.
Trzeciak ER; Department of Dermatology, University Medical Center Mainz, Johannes Gutenberg University Mainz, Mainz, Germany.
Graefen B; Department of Dermatology, University Medical Center Mainz, Johannes Gutenberg University Mainz, Mainz, Germany.
Satoh K; Early Clinical Development Department, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
Tuettenberg A; Department of Dermatology, University Medical Center Mainz, Johannes Gutenberg University Mainz, Mainz, Germany.

Front Immunol ; 13: 928450, 2022.

Article en En | MEDLINE | ID: mdl-35898500

Asunto(s)

Neoplasias; Linfocitos T Reguladores; Autoinmunidad; Glicoproteínas/metabolismo; Humanos; Proteínas de la Membrana/metabolismo; Microambiente Tumoral

Palabras clave

GARP mRNA; Glycoprotein A repetitions predominant (GARP); LRRC32; Soluble GARP or soluble Glycoprotein A repetitions predominant (sGARP); Treg; biomarker; therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T Reguladores / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google